In terms of the molecular subtypes of BLCA, the THEM6-high expression group was more inclined towards the luminal subtype and its signatures, while the THEM6-low expression group towards the basal subtype and its signatures (Figure 5(d)). Here, THEM6 is linked to bladder transitional cell carcinoma.